Correlation Between Adimmune Corp and Tanvex BioPharma

Can any of the company-specific risk be diversified away by investing in both Adimmune Corp and Tanvex BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adimmune Corp and Tanvex BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adimmune Corp and Tanvex BioPharma, you can compare the effects of market volatilities on Adimmune Corp and Tanvex BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adimmune Corp with a short position of Tanvex BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adimmune Corp and Tanvex BioPharma.

Diversification Opportunities for Adimmune Corp and Tanvex BioPharma

0.06

Correlation Coefficient

Adimmune Corp  Tanvex BioPharma

Significant diversification

The 3 months correlation between Adimmune and Tanvex is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Adimmune Corp and Tanvex BioPharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tanvex BioPharma and Adimmune Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adimmune Corp are associated (or correlated) with Tanvex BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tanvex BioPharma has no effect on the direction of Adimmune Corp i.e., Adimmune Corp and Tanvex BioPharma go up and down completely randomly.

Pair Corralation between Adimmune Corp and Tanvex BioPharma

Assuming the 90 days trading horizon Adimmune Corp is expected to under-perform the Tanvex BioPharma. But the stock apears to be less risky and, when comparing its historical volatility, Adimmune Corp is 1.63 times less risky than Tanvex BioPharma. The stock trades about -0.29 of its potential returns per unit of risk. The Tanvex BioPharma is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  6,370  in Tanvex BioPharma on October 10, 2024 and sell it today you would earn a total of  40.00  from holding Tanvex BioPharma or generate 0.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.41%
Values	Daily Returns

Adimmune Corp  vs.  Tanvex BioPharma

Adimmune Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Adimmune Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Tanvex BioPharma

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Tanvex BioPharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Tanvex BioPharma is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Adimmune Corp and Tanvex BioPharma

The main advantage of trading using opposite Adimmune Corp and Tanvex BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adimmune Corp position performs unexpectedly, Tanvex BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tanvex BioPharma will offset losses from the drop in Tanvex BioPharma's long position.

The idea behind Adimmune Corp and Tanvex BioPharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.